PHARMA MAR, S.A. The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 18/01/2018 19:00 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks CORAIL Phase III with Zepsire in resistant ovarian cancer has not met its primary endpoint. Register number: 260786